Phase II Study of Irinotecan and Panitumumab

Clinical trial NCT00836277 · COMPLETED

Trial details

NCT number: NCT00836277
Sponsor: Weijing Sun, MD, FACP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2009-05-01
Primary completion: 2015-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.